Justin Klein Op-Ed: CMS Can Make RAPID a Win for Patients and American Medtech Innovation 

With the Right Steps, RAPID Could Have a Wide Impact  

In this op-ed published in Medtech Insight, Justin Klein, MD, JD, explains how the proposed RAPID coverage pathway could accelerate Medicare access to breakthrough medical technologies and why targeted refinements are essential to its success. 

Klein urges the Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) to establish firm milestones, ensure adequate staffing, and provide flexible eligibility. These improvements would help give medtech startups the predictability they need to bring proven innovations to patients sooner. 

The op-ed highlights the stakes for patients and the small businesses developing new treatment options. Klein makes the case that a more predictable path to Medicare coverage can help RAPID fulfill its promise: getting proven technologies to patients before preventable illness becomes irreversible or hospital care becomes unavoidable.